Policy | March 16, 2023
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Biocorp will receive an initial milestone payment this year
Time to combine innovation, access and technology to deliver positive patient outcomes
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Subscribe To Our Newsletter & Stay Updated
